The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.
Nasdaq: ALXN
Change
symbol:
     
 PROFILE
Alexion Pharmaceuticals can't suppress its enthusiasm for treating immune functions gone awry. The firm develops drugs that inhibit certain immune system functions that cause autoimmune, cardiovascular, and neurological diseases. One lead candidate, developed with Proctor & Gamble, targets inflammation following cardiopulmonary bypass surgery, and another candidate targets rheumatoid arthritis and lupus. Alexion made a splash by curing spinal injuries in rodents with genetically altered pig cells: Its work in xenotransplantation is in concert with development of a T-cell inhibitor technology (used for xenotransplantation) to treat multiple sclerosis, Parkinson's disease, and other neurological disorders.

 COMPETITION
AVANT Immunotherapeutics, Inc. (AVAN)
Abbott Laboratories (ABT)
BioCryst Pharmaceuticals, Inc. (BCRX)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: July
2000 Sales (mil.): 21.40
1-Yr. Sales Growth: 13.8%
Employees: 113
Revenue per employee: $189,380.53

 KEY PEOPLE
• Leonard Bell
    CEO
• Barry P. Luke
    CFO

 CONTACT INFO
25 Science Park
New Haven, CT 06511
US
Phone: 203-776-1790
Fax: 203-772-3655
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001